“Both CME surveillance can detect spot-market fraud that impacts each futures ETFs and spot exchange-traded merchandise, or that surveillance can not achieve this for both kind of product,” the submitting stated. “Having authorized ETH futures ETFs partly on the premise of such surveillance, the Fee has clearly decided that CME surveillance can detect spot-market fraud that might have an effect on spot ETPs, and the Sponsor thus believes that it should additionally approve spot ETH ETPs on that foundation.”
